Introduction
============

Acute cholangitis (AC) is a bacterial infection caused by obstruction of the bile duct,[@b1-ceg-7-447]--[@b3-ceg-7-447] and should be treated promptly to prevent fatal sepsis.[@b4-ceg-7-447],[@b5-ceg-7-447] Biliary drainage is usually performed through endoscopic retrograde cholangiopancreatography (ERCP),[@b6-ceg-7-447] but papillotomy is necessary for biliary drainage in the treatment of AC.[@b7-ceg-7-447] Juxtapapillary diverticulum (JD) is associated with an increased risk of cholangiopancreatic diseases, such as obstructive jaundice, AC, and acute pancreatitis.[@b8-ceg-7-447]--[@b10-ceg-7-447] The success rate of cannulation is controversial with ERCP for patients with JD,[@b11-ceg-7-447],[@b12-ceg-7-447] the latter being a risk factor for sphincterotomy.[@b8-ceg-7-447] JD is an outpouching of mucosa and muscularis mucosa that arises in the duodenal window, located at the interruption of the duodenal muscle fibers where the common bile duct (CBD) and main pancreatic duct penetrate the duodenal wall.[@b13-ceg-7-447] The mechanism underlying the association between AC and JD, however, is not known. The aim of the present study was to compare laboratory variables in AC patients with or without JD to identify the potential mechanism underlying the association between these two conditions.

Materials and methods
=====================

Patients
--------

Patient records were retrospectively analyzed from April 2008 to March 2013. The institutional ethics committee reviewed our study, and determined that it was not a clinical trial because it was performed as a part of daily clinical practice. Written informed consent was obtained for each session of ERCP and from patients who underwent contrast-enhanced computed tomography (CECT) or magnetic resonance CP (MRCP). Patient anonymity was preserved. ERCP was performed for patients with suspected AC, bile-duct cancer, gallbladder cancer, pancreatic cancer, or intraductal papillary neoplasm. ERCP was also performed for patients with bile-duct stricture and other biliary or pancreatic conditions.[@b14-ceg-7-447] In this study, JD was not categorized.[@b12-ceg-7-447] Bile-duct dilatation was defined as a bile-duct diameter \>7 mm as seen on abdominal ultrasonography, MRCP, CECT, or ERCP. The laboratory data analyzed in this study were white blood cell (WBC) count and C-reactive protein (CRP), total bilirubin, alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase, and γ-glutamyl transpeptidase (γ-GTP) levels, all important variables for the diagnosis of AC.[@b6-ceg-7-447],[@b15-ceg-7-447]

Diagnostic criteria for acute cholangitis
-----------------------------------------

Patients were diagnosed with AC when they had fever, abdominal pain, and jaundice (Charcot's triad). If a patient did not meet the Charcot's triad criteria, AC was diagnosed when they showed an inflammatory response, consisting of fever and elevation of WBC count or CRP level, and biliary obstruction involving bile-duct dilatation, biliary stricture, CBD stones, and elevation of ALP or γ-GTP levels. The severity of AC was assessed following the Tokyo Guidelines.[@b16-ceg-7-447]

Endoscopic retrograde cholangiopancreatography
----------------------------------------------

ERCP was performed by experienced endoscopists with a duodenoscope (JF-260V; Olympus, Tokyo, Japan). Papillotomy was performed with a pull-type sphincterotome (Boston Scientific, Natick, MA, USA). Stones and sludge were removed with a basket or balloon catheter, and a nasobiliary catheter was inserted for drainage if necessary.

Imaging diagnostics
-------------------

Patients with suspected AC underwent CECT and abdominal ultrasonography to further investigate biliary dilatation, CBD stones, and cancer. After May 2012, the patients underwent MRCP with a 1.5 T scanner (Achieva Software version 3.2.2; Philips Medical Systems, Best, Netherlands). Before May 2012, some of the patients were referred to Sannou Hospital (Chiba City, Japan) for MRCP. CECT was performed using a 16-detector-row CT scanner (Somatom Emotion 16; Siemens, Munich, Germany). Patients were administered intravenous contrast medium containing 100 mL of iopamidol at 3 mL/s (Konica Minolta Healthcare, Tokyo, Japan). CT images were acquired before the injection of contrast medium and at 30, 70, and 180 seconds later. Abdominal ultrasonography was performed by senior fellows at the Japan Society of Ultrasonics in Medicine with an SSA-700A instrument (Toshiba Medical Systems, Ohtawara, Japan) using a 5.0 MHz curved-array transcutaneous probe or an 8.0 MHz linear array transcutaneous probe.

Statistical analysis
--------------------

The Wilcoxon signed-rank test was used for comparison of baseline variables. The *χ*^2^ test was used to assess the association between JD and AC symptoms. Logistic regression analysis was performed to identify the variables that strongly correlated with AC. JMP software version 10.0.2 (SAS Institute, Cary, NC) was used for statistical analysis. *P*\<0.05 was considered statistically significant.

Results
=======

ERCP was attempted in 139 patients, but in one patient the endoscope did not reach the papilla of Vater because of a partial gastrectomy, and in two patients evaluation for JD was not possible because of duodenal or papilla of Vater cancer. Therefore, 136 patients were analyzed in this study.

The baseline characteristics of patients are shown in [Table 1](#t1-ceg-7-447){ref-type="table"}. Thirty-seven patients had JD (27.2%). Age was not correlated with the presence or absence of JD, but ALP level was significantly elevated in patients with JD (*P*=0.0237). No significant differences in baseline characteristics were noted between AC patients with JD or those without JD ([Table 2](#t2-ceg-7-447){ref-type="table"}).

Our analysis of the association of JD with AC or bile-duct dilatation ([Table 3](#t3-ceg-7-447){ref-type="table"}) revealed that JD was significantly associated with both AC (*P*\<0.0001) and bile-duct dilatation (*P*=0.0107). The correlation of AC and bile-duct dilation was then analyzed with the *χ*^2^ test ([Table 4](#t4-ceg-7-447){ref-type="table"}), which revealed a strong association of AC with bile-duct dilatation (*P*=0.0013).

Because symptoms are diagnostic clues to AC, we analyzed the correlation between JD and AC symptoms ([Table 5](#t5-ceg-7-447){ref-type="table"}). Although there was a tendency for a correlation of abdominal pain with JD, it was not significant (*P*=0.2117).

To reveal whether any laboratory data variables correlated with AC, logistic regression analysis was applied. The patients with AC were divided into those with or without JD. [Table 6](#t6-ceg-7-447){ref-type="table"} shows the results of logistic regression analysis with AC patients without JD. The *χ*^2^ of CRP was 4.48 (*P*=0.0342). For AC patients with JD, the *χ*^2^ values for WBC count, ALP, and AST were 2.62, 3.1, and 3.16, respectively (*P*=0.0251, 0.015, and 0.0336, respectively; [Table 7](#t7-ceg-7-447){ref-type="table"}). No other laboratory parameters correlated with AC patients without JD.

Discussion
==========

JD has been found in 32.8% of consecutive patients subjected to ERCP, and is classified into three types based on the position of the papilla of Vater: type 1, inside the diverticulum; type 2, in the margin of the JD; and type 3, near the JD.[@b12-ceg-7-447] In our series, JD was found in 27.2% of patients who underwent ERCP, which is consistent with previous reports.

It is reported that JD is associated with CBD stones and bile-duct dilatation,[@b8-ceg-7-447],[@b17-ceg-7-447] although JD may be associated with bile-duct dilatation even in patients with normal levels of liver enzymes.[@b18-ceg-7-447],[@b19-ceg-7-447] Our data are consistent with previous reports. It is speculated that the anatomical abnormalities of JD may play an important role in the formation of bile-duct pigment stones.[@b20-ceg-7-447] The relation between bile-duct dilatation and AC is strong enough for bile-duct dilatation to be a criterion for the diagnosis of AC, possibly suggesting bile-duct obstruction.[@b16-ceg-7-447] On the other hand, the mechanism underlying the association between JD and bile-duct dilatation is unclear.

In the present study, ALP levels were higher in patients with JD than in those without JD. With regard to only patients with AC, there was no difference in ALP levels between patients with or without JD. These data suggest that bile flow might be disturbed with JD. Once AC occurs and ALP level is elevated, any difference between patients with and without JD may be obscured. The incidence of positive bacterial bile cultures is significantly higher in patients with JD than in those without,[@b21-ceg-7-447] which combined with our data suggests that bile flow might be disturbed with JD and that bacterial infection is present more often in the bile ducts of patients with JD than in those without. Therefore, bile-duct pigment stones formed more often in patients with JD than in those without.[@b20-ceg-7-447]

The sphincter of Oddi regulates bile flow and prevents AC.[@b22-ceg-7-447] AC is caused by obstruction of the bile duct, mainly by CBD stones.[@b1-ceg-7-447],[@b2-ceg-7-447] In the present study, the laboratory variables correlating with AC were different between patients with or without JD. CRP was the only variable that correlated with AC in patients without JD, whereas WBC count and ALP and AST levels were correlated with AC in patients with JD. WBC count and CRP level indicate inflammation, whereas ALP and AST levels represent bile-duct obstruction. Our data suggest that bile flow was disturbed in patients with JD. It has been speculated that JD disturbs the motility of the duodenum and pressure of the sphincter of Oddi, leading to increased infection of the bile duct in concert with bacterial overgrowth in the diverticulum. The infection might be enhanced in the presence of edema and partial obstruction of the bile duct with CBD stones. This hypothesis could be demonstrated by measuring bile-duct pressure with a manometer during ERCP.[@b23-ceg-7-447] A potential concern is that JD could be a risk factor for complications, such as bleeding, infection, and acute pancreatitis. To reduce this risk, endoscopic papillary large-balloon dilatation is recommended for patients with JD.[@b24-ceg-7-447] It would be preferable for AC patients with JD to undergo more frequent follow-ups after treatment, because they could be prone to AC relapse. Further studies measuring the pressure of the sphincter of Oddi using a manometer are needed to provide more details of this association. In conclusion, our study findings showed that JD was strongly associated with AC and that bile flow was disturbed with JD, based on laboratory data.
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###### 

Comparison of laboratory data between patients with and without juxtapapillary diverticulum

               Without juxtapapillary diverticulum (n =98)   With juxtapapillary diverticulum (n =37)   *P*-value                  
  ------------ --------------------------------------------- ------------------------------------------ ----------- -------------- --------
  Age, years   69.2                                          67.2--71.2                                 69.0        65.7--72.3     0.8989
  WBC          7,391                                         6,551--8,232                               8,308       6,940--9,676   0.2610
  CRP          2.62                                          1.57--3.67                                 4.12        2.39--5.85     0.1448
  T-Bil        1.54                                          1.04--2.05                                 1.81        0.99--2.63     0.5821
  ALP          447                                           365--529                                   626         495--757       0.0237
  AST          119                                           77--160                                    124         57--192        0.8873
  ALT          118                                           84--151                                    140         85--194        0.4962
  γ-GTP        249                                           181--316                                   341         231--451       0.1575

**Note:** *P*-values were determined by Wilcoxon's signed-rank test.

**Abbreviations:** CI, confidence interval; WBC, white blood cell; CRP, C-reactive protein; T-Bil, total bilirubin; ALP, alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GTP, glutamyl transpeptidase.

###### 

Comparison of laboratory data between patients with acute cholangitis with and without juxtapapillary diverticulum

          Without juxtapapillary diverticulum (n =27)   With juxtapapillary diverticulum (n =26)   *P*-value                   
  ------- --------------------------------------------- ------------------------------------------ ----------- --------------- --------
  Age     69.4                                          65.6--73.3                                 68.8        64.8--72.3      0.5989
  WBC     10,122                                        8,075--12,169                              9,080       6,995--11,166   0.3502
  CRP     6.19                                          3.65--8.73                                 4.83        2.19--7.47      0.6207
  T-Bil   2.93                                          1.59--4.27                                 2.03        0.67--3.40      0.8033
  ALP     639                                           475--804                                   713         548--877        0.9854
  AST     209                                           123--295                                   123         36--211         0.2332
  ALT     204                                           131--276                                   149         78--220         0.5783
  γ-GTP   350                                           227--474                                   382         256--508        0.5591

**Note:** *P*-values were determined by Wilcoxon's signed-rank test.

**Abbreviations:** CI, confidence interval; WBC, white blood cell; CRP, C-reactive protein; T-Bil, total bilirubin; ALP, alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GTP, glutamyl transpeptidase.

###### 

Correlation between juxtapapillary diverticulum and acute cholangitis or bile-duct dilatation

                                Acute cholangitis (*P*\<0.0001)   Bile-duct dilatation (*P*=0.0107)   Total        
  ----------------------------- --------------------------------- ----------------------------------- ------- ---- -----
  Juxtapapillary diverticulum                                                                                      
   −                            72                                27                                  59      40   99
   +                            11                                26                                  13      24   37
  Total                         83                                53                                  72      64   136

**Note:** *P*-values were determined by *χ*^2^ test.

###### 

Correlation between acute cholangitis and bile-duct dilatation

                      Bile-duct dilatation   Total   
  ------------------- ---------------------- ------- -----
  Acute cholangitis                                  
   −                  53                     30      83
    +                 19                     34      53
  Total               72                     64      136

**Note:** *P*=0.0013 (*χ*^2^ test).

###### 

Correlation between juxtapapillary diverticulum and symptoms of acute cholangitis

                                Abdominal pain (*P*=0.2117)   Total   Fever (*P*=0.6854)   Total   Jaundice (*P*=0.8928)   Total             
  ----------------------------- ----------------------------- ------- -------------------- ------- ----------------------- ------- ---- ---- ----
  Juxtapapillary diverticulum                                                                                                                
   −                            8                             19                           12      15                              14   13   27
   +                            4                             22                           13      13                              13   13   26
  Total                         24                            45                           25      28                              27   26   69

**Note:** *P*-values were determined by *χ*^2^ test.

###### 

Logistic regression analysis of patients with acute cholangitis without juxtapapillary diverticulum

          *χ*^2^       OR          95% CI of OR         *P*-value
  ------- ------------ ----------- -------------------- -----------
  WBC     1.61         1.0001084   0.999709--1.000055   0.2052
  CRP     4.48         1.176696    0.721717--0.979098   0.0342
  T-Bil   1.49         1.1781629   0.580052--1.057499   0.2226
  ALP     1.1×10^−6^   0.9999953   0.997434--1.002703   0.9972
  AST     0.19         1.001254    0.991369--1.004106   0.6660
  ALT     0.27         1.0018022   0.991558--1.00594    0.6040
  γ-GTP   0.03         1.0002375   0.991558--1.002736   0.8616

**Note:** *P*-values were determined by logistic regression analysis.

**Abbreviations:** OR, odds ratio; CI, confidence interval; WBC, white blood cell; CRP, C-reactive protein; T-Bil, total bilirubin; ALP, alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GTP, glutamyl transpeptidase.

###### 

Logistic regression analysis of patient with acute cholangitis with diverticulum

          *χ*^2^   OR           95% CI of OR         *P*-value
  ------- -------- ------------ -------------------- -----------
  WBC     2.62     1.000497     0.998739--0.999954   0.0251
  CRP     2.98     0.6993023    0.987904--2.373463   0.0582
  T-Bil   1.17     1.77331172   0.168276--1.456388   0.2509
  ALP     3.10     1.0044708    0.988934--0.999331   0.0150
  AST     3.61     0.989096     1.000797--1.024472   0.0336
  ALT     0.28     1.0033479    0.982806--1.008615   0.5874
  γ-GTP   0.08     1.0005787    0.994856--1.003876   0.7741

**Note:** *P*-values were determined by logistic regression analysis.

**Abbreviations:** OR, odds ratio; CI, confidence interval; WBC, white blood cell; CRP, C-reactive protein; T-Bil, total bilirubin; ALP, alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GTP, glutamyl transpeptidase.
